News

Evervie Health Limited, formerly known as PVP Ventures Limited, announced it signed a Letter of Intent with Elekta Solutions AB of Sweden for the procurement of ten HARMONY linear accelerator (LINAC) systems, with a deal value expected to be between 11 to 15 million United States dollars, payable in Swedish krona. The systems will be operated by Evervie Health’s subsidiary, Optimus Oncology Private Limited, and the procurement is subject to execution of a definitive Purchase and License Agreement, approvals, financing, and contractual conditions. Additionally, Evervie Health launched its new official website, https://everviehealth.com, replacing the previous www.pvpglobal.com, effective October 20, 2026.

Evervie Health Limited, formerly known as PVP Ventures Limited, submitted a certificate to the National Stock Exchange of India Limited and BSE Limited on October 9, 2026, confirming the dematerialization of securities for the quarter ended September 30, 2026, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, with KFin Technologies Limited acting as the Registrar and Share Transfer Agent.

PVP Ventures Limited will close its trading window for designated persons, immediate relatives, and insiders starting October 1, 2026, and continuing until 48 hours after the declaration of the company’s unaudited financial results for the quarter and half-year ended September 30, 2026, in compliance with SEBI regulations.

PVP Ventures Limited has fixed Wednesday, September 23, 2026, as the record date for interest payments on its Non-Convertible Debentures (NCDs) with ISINs INE362A07054 and INE362A07047, with payments scheduled for Thursday, October 8, 2026, according to a filing with the National Stock Exchange of India Limited and BSE Limited.

PVP Ventures Limited announced the appointment of Mr. Vinay Paruchuru as Company Secretary & Compliance Officer, effective September 14, 2026, and the resignation of Mr. B Vignesh Ram from the same position, effective September 11, 2026.